B/26. Semisynthetic and synthetic opiates Flashcards
Drugs need to know in this topic
Strong agonist
Hydromorphone
Fentanyl
Meperidine
Oxycodone
Methadone
Weak agonist
Tramadol
Loperamide
Diphenoxylate
Dihydrocodeine
Dextromethorphan
Mixed activity
Buprenorphine
Nalbuphine
Opioid antagonists
Naloxone
Methyl
Naltrexone
Hydromorphone
Strong agonist Semi-synthetic 1. Analgesic use (post-operative pain, chronic pain syndromes)
Fentanyl
Strong agonist synthetic 1. Analgesic use (post-operative pain, chronic pain syndromes); transdermal/sublingual 2. Anesthesia
Tramadol
Weak agonist
Synthetic
- Analgesic use (neuropathic pain, dentistry)
*NE and 5-HT reuptake inhibition (serotonin syndrome)
Meperidine
Strong agonist
Synthetic
- Analgesic use (emergency care, pre-operative)
*Anti-muscarinic effect; metabolite has serotonergic activity (serotonin syndrome)
Oxycodone
Strong agonist
Semi-synthetic
- Analgesic use (post-operative pain, chronic pain syndromes) *Potential drug of abuse
Loperamide
Weak agonist
Synthetic
- Anti-diarrheal agents
*Loperamide has no CNS effects
Diphenoxylate
Weak agonist
Synthetic
- Anti-diarrheal agents
Dihydrocodeine
Weak agonist
Semi-synthetic
- Antitussive
- Analgesic effect in combination with NSAID’s or acetaminophen
*NE and 5-HT reuptake inhibition (dextromethorphan)
Dextromethorphan
Weak agonist
Synthetic
- Antitussive
- Analgesic effect in combination with NSAID’s or acetaminophen
*NE and 5-HT reuptake inhibition (dextromethorphan)
Methadone
Strong agonist
Synthetic
- Management of opioid withdrawal syndrome
- Maintenance programs for addicts (heroin, morphine)
*Long serum T1/2
Buprenorphine
Mixed activity
Semi-synthetic
- Management of opioid withdrawal syndrome
- Maintenance programs for addicts (heroin, morphine)
*Long serum T1/2
Nalbuphine
Mixed activity
Semi-synthetic
- Spinal anesthesia
Naloxone
Strong antagonist
Semi-synthetic
- Management of acute opioid overdose (IV administration only)
*T1/2 1-2 h’
Methyl Naltrexone
Strong antagonist Synthetic
- Management of opioid withdrawal syndrome (oral administration)
- Management of alcohol withdrawal syndrome
*Long serum T1/2 up to 48 h’